# Interstitial Lung Disease Research Unit Biobank

> **NCT05392881** · — · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Interstitial Lung Disease
- Sarcoidosis
- Idiopathic Pulmonary Fibrosis
- Pulmonary Fibrosis
- Hypersensitivity Pneumonitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05392881
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-09
- **Primary completion:** 2031-08-01
- **Final completion:** 2032-03-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392881, "Interstitial Lung Disease Research Unit Biobank". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05392881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*